Inhaled corticosteroid therapy does not control asthma

Canadian Respiratory Journal

Volumn 11, Issue 8, 2004, Pages 555-558

  Cowie, Robert L ^a,b   Underwood, Margot F ^a   Field, Stephen K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Health Sciences Centre Calgary   (Canada)

Author keywords

Asthma control; Cross sectional study; Inhaled corticosteroid; Severity

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CANADA; COMMUNITY CARE; CONFIDENCE INTERVAL; CONSENSUS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SELF REPORT; STATISTICAL ANALYSIS; UNIVERSITY;

EID: 11844271974     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/967972     Document Type: Article

References (24)

1. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis 1993;148:S1-S26.
2. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-92.
3. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990;142:832-6.
4. Ernst P, Spitzer WO, Suissa S, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992;268:3462-4.
5. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
6. Anis AH, Lynd LD, Wang XH, et al. Double trouble: Impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001;164:625-31.
7. National Heart Lung and Blood Institute. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. Bethesda: National Institutes of Health, 1997.
8. Ernst P, FitzGerald JM, Spier S. Canadian Asthma Consensus Conference: Summary of recommendations. Can Respir J 1996;3:89-100.
9. British Thoracic Society, National Asthma Campaign, Royal College of Physicians of London in association with the General Practioner in Asthma Group, et al. The British guidelines on asthma management 1995. Review and position statement. Thorax 1997;52:S1-S21.
10. Bateman ED, Bousquet J, Braunstein GL. Is overall asthma control being achieved? A hypothesis-generating study. Eur Respir J 2001;17:589-95.
11. Boulet LP. Asthma therapy: Effects on airway inflammation and remodelling. Can Respir J 1998;5:68-70.
12. Ungar WJ, Coyte PC, Chapman KR, MacKeigan L. The patient level cost of asthma in adults in south central Ontario. Pharmacy Medication Monitoring Program Advisory Board. Can Respir J 1998;5:463-71.
13. Vollmer WM, Markson LE, O'Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999;160:1647-52.
14. Vollmer WM, Markson LE, O'Connor E, Frazier EA, Berger M, Buist AS. Association of asthma control with health care utilization: A prospective evaluation. Am J Respir Crit Care Med 2002;165:195-9.
15. Cowie RL, Underwood MF, Revitt SG, Field SK. Predicting emergency room utilization in adults with asthma: A cohort study. J Asthma 2001;38:179-84.
16. Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 1996;98:1016-8.
17. Ungar WJ, Chapman KR, Santos MT. Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med 2002;165:190-4.
18. Unwin D, Jones K, Hargreaves C, Gray J, for the Eden Valley General Practice Research Group. Using a revised asthma morbidity index to identify varying patterns of morbidity in UK general practices. Respir Med 2001;95:1006-11.
19. Legorreta AP, Christian-Herman J, O'Connor RD, Hasan MM, Evans R, Leung KM. Compliance with national asthma management guidelines and specialty care: A health maintenance organization experience. Arch Intern Med 1998;158:457-64.
20. Milgrom H, Bender B, Ackerson L, Bowry P, Smith H, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-7.
21. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002;19:246-51.
22. Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest 1998;113:587-92.
23. Chapman KR, Ernst P, Grenville A, Dewland P, Zimmerman S. Control of asthma in Canada: Failure to achieve guideline targets. Can Respir J 2001;8(Suppl A):35A-40A.
24. Crapo R, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-64.